It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn effective ways to make fast cash while working from home. These tips can help you enhance your income quickly.
28,086 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
As the infrastructure megatrend gathers steam, a single ETF could anchor your 2026 strategy. Learn which fund stands ...
Perella Weinberg stock lags the broader market, even as a major fund just boosted its stake by about $15 million. Thi...
Lululemon is set to report its Q1 results tonight as margins, growth mix, and international exposure take center stag...
A top market analyst says the popular rotation narrative is flawed. New ETF flow data show bitcoin didn’t lose gold, ...
Hydrogen names tumble after a monster 2026 run, led by FuelCell Energy, Bloom Energy, and Plug Power. The market back...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
U.S. farmers confront renewed uncertainty as a China summit closes without a clear deal, while Iran's conflict drives...
A 71-year-old caller on The Ramsey Show admitted to panic-selling her retirement savings twice during the COVID marke...
Veteran investor Jeremy Grantham warns that U.S. stock valuations have grown extremely stretched, signaling a potenti...
Nike's latest sponsorship moves suggest a gradual return of brand influence and profit potential. This article explor...
Oil holds above $90, giving EWZ a turbocharged push as Petrobras and Vale ride commodity tailwinds. The Brazil-focuse...